Absentia Labs Company

Absentia Labs is a next-generation drug discovery platform using in-silico whole-organism models to replace traditional animal testing. With over 92% of animal models failing to translate to humans, our physics-AI model offers a more accurate, ethical, and cost-effective solution. We have already created cell differentiation, reprogramming, drug absorption, tissue regeneration, and embryonic development in mice, and plan to scale our model and expand to other model organisms to reach its full potential. Our product will provide a cheaper, faster and more ethical alternative for preclinical drug development, accelerating the drug discovery process while improving success rates

Founded Date: 2024-11-19
Industry: Quantum Biology
Last Funding Date: 2025-08-22
Funding Status: private
Headquarters: Boston,Massachusetts,United States,North America
Super Industry: Quantum Science Applications
Funding Stage: Seed
Founders: Farhan Khodaee